New study aims to catch pancreatic cancer early in High-Risk individuals

NCT ID NCT05006131

Recruiting now Diagnosis Sponsor: Beth Israel Deaconess Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study is testing whether regular screening with endoscopic ultrasound (EUS) or MRI can find early signs of pancreatic cancer in people at high risk. About 1,395 participants will be screened, and researchers will track how many have high-risk lesions that can be treated. The goal is to improve early detection and outcomes for this deadly cancer.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could show that regular screening helps catch pancreatic cancer early in high-risk people, potentially improving survival.
What could go wrong: This is an observational screening study, not a treatment trial. It may not prove that screening reduces deaths, and some findings could be false alarms leading to unnecessary procedures.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER, ADULT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

familial pancreatic carcinoma malignant pancreatic neoplasm Pancreatic cancer, adult

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PANCREATIC CANCER, ADULT

Contacts and locations

Locations

Beth Israel Deaconess Medical Center
RECRUITING

Boston, Massachusetts, 02215, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.